Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review

Immune checkpoint inhibitors (ICIs) are a new class of cancer pharmacotherapy consisting of antibodies that block inhibitory immune regulators such as cytotoxic T lymphocyte antigen 4, programmed cell death 1 and programmed death-ligand 1. Checkpoint blockade by ICIs reactivates a tumor-specific T c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hua, Fu, Zhi-Yan, Arslan, Mustafa Erdem, Cho, Daniel, Lee, Hwajeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553980/
https://www.ncbi.nlm.nih.gov/pubmed/36246150
http://dx.doi.org/10.5493/wjem.v11.i6.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553980/
https://www.ncbi.nlm.nih.gov/pubmed/36246150
http://dx.doi.org/10.5493/wjem.v11.i6.79

Ejemplares similares